The global N95 medical protective masks market size was USD 3.26 billion in 2023, calculated at USD 3.55 billion in 2024 and is expected to reach around USD 8.25 billion by 2034, expanding at a CAGR of 8.8% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. N95 Medical Protective Masks Market, by Product Type, 2024-2034
7.1.1. Mask without Exhalation Valve
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. Mask with Exhalation Valve
7.1.2.1. Market Revenue and Forecast (2021-2034)
8.1. N95 Medical Protective Masks Market, by Application, 2024-2034
8.1.1. Personal
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Industrial
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. N95 Medical Protective Masks Market, by End-use, 2024-2034
9.1.1. Drug Stores
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Online Stores
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2021-2034)
10.1.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.3. Market Revenue and Forecast, by End-use (2021-2034)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.1.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.5.3. Market Revenue and Forecast, by End-use (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2021-2034)
10.2.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.3. Market Revenue and Forecast, by End-use (2021-2034)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.2.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.5.3. Market Revenue and Forecast, by End-use (2021-2034)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
10.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.6.3. Market Revenue and Forecast, by End-use (2021-2034)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
10.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.7.3. Market Revenue and Forecast, by End-use (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2021-2034)
10.3.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.3. Market Revenue and Forecast, by End-use (2021-2034)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.3.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.5.3. Market Revenue and Forecast, by End-use (2021-2034)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
10.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.6.3. Market Revenue and Forecast, by End-use (2021-2034)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
10.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.7.3. Market Revenue and Forecast, by End-use (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.4.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.5.3. Market Revenue and Forecast, by End-use (2021-2034)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
10.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.6.3. Market Revenue and Forecast, by End-use (2021-2034)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
10.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.7.3. Market Revenue and Forecast, by End-use (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.3. Market Revenue and Forecast, by End-use (2021-2034)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.5.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.5.3. Market Revenue and Forecast, by End-use (2021-2034)
11.1. Honeywell International Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. 3M
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Kowa Company Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Kimberly-Clark Worldwide, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Prestige Ameritech
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. ANSELL LTD.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Cardinal Health
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. JIANGSU TEYIN IMP. & EXP. CO., LTD.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. The Gerson Company
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Ohlone Press LLC
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Cambridge Mask Co
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample